Hims & Hers Health Inc [HIMS] stock is trading at $35.04, up 23.03%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HIMS shares have gain 38.22% over the last week, with a monthly amount glided 20.25%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on April 29, 2025, when TD Cowen downgraded its rating to a Hold but kept the price target unchanged to $30 for it. Previously, Morgan Stanley downgraded its rating to Equal-Weight on February 18, 2025, and elevated its price target to $60. On January 10, 2025, downgrade downgraded it’s rating to Sell and revised its price target to $25 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $35 on January 07, 2025. Morgan Stanley initiated its recommendation with a Overweight and recommended $42 as its price target on December 17, 2024. BofA Securities downgraded its rating to Underperform for this stock on November 14, 2024. In a note dated August 22, 2024, Needham initiated an Buy rating and provided a target price of $24 on this stock.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $11.20 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $39 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $35.04 at the most recent close of the market. An investor can expect a potential return of 11.3% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.48B for the trailing twelve months, which represents a growth of 95.09%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at 0.05%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.31 and Total Capital is 0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 32.68 points at the first support level, and at 30.32 for the second support level. However, for the 1st resistance point, the stock is sitting at 37.67, and for the 2nd resistance point, it is at 40.30.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 1.79. As well, the Quick Ratio is 1.50, while the Cash Ratio is 1.0. Considering the valuation of this stock, the price to sales ratio is 5.27, the price to book ratio is 16.23 and price to earnings (TTM) ratio is 65.52.
Transactions by insiders
Recent insider trading involved Dudum Andrew, Officer, that happened on Apr 29 ’25 when 50000.0 shares were purchased. Officer, Dudum Andrew completed a deal on Apr 28 ’25 to buy 41667.0 shares. Meanwhile, Officer Boughton Soleil bought 3236.0 shares on Apr 28 ’25.
